Sung-Dae Hong is currently the Chief Executive Officer and Board Member of StatLab, a portfolio company of Audax Private Equity and Linden Capital Partners. StatLab is a leading specialty developer and manufacturer providing histology, cytology, and immunohistochemistry consumables and equipment to more than 3,000 anatomical pathology laboratories throughout the United States, United Kingdom, and other international markets. Previously, Dae was President of the Laboratory Products Division at Thermo Fisher Scientific where he oversaw a global organization of 9,000 colleagues and $2.5B in revenue, with laboratory equipment and consumables serving life sciences and diagnostics applications. Dae joined Thermo Fisher as the Head of Corporate Strategy in 2011 and held multiple Vice President / General Manager roles over a 10-year span. Dae spent the first decade of his career as a management consultant at Bain & Company across four continents (Australia, Korea, Europe, U.S.) and led projects in M&A, growth strategy, and commercial due diligence. Dae was born in South Korea, immigrated to Australia as a young child, and then moved to the Boston area to attend graduate school, where he lives today. He holds honors degrees in law and finance from the University of Melbourne, and an MBA from the MIT Sloan School of Management, where he graduated as the Henry Ford II Scholar. In addition to the BPO Board position, Dae serves as a Senior Advisory Board Member of AsianUpward, on the Board of the Jennifer Price Global Education Leadership Fund, and on the Advisory Board of the Harvard Extension School’s Business and Management Programs.

New call-to-action